Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Avram 2021 Int J Mol Sci"

From Bioblast
(Created page with "{{Publication |title=Avram VF, Chamkha I, Åsander-Frostner E, Ehinger JK, Timar RZ, Hansson MJ, Muntean DM, Elmér E (2021) Cell-permeable succinate rescues mitochondrial res...")
 
(5 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{Publication
{{Publication
|title=Avram VF, Chamkha I, Åsander-Frostner E, Ehinger JK, Timar RZ, Hansson MJ, Muntean DM, Elmér E (2021) Cell-permeable succinate rescues mitochondrial respiration in cellular models of statin toxicity. Int J Mol Sci 22:424.
|title=Avram VF, Chamkha I, Åsander-Frostner E, Ehinger JK, Timar RZ, Hansson MJ, Muntean DM, Elmér E (2021) Cell-permeable succinate rescues mitochondrial respiration in cellular models of statin toxicity. Int J Mol Sci 22:424.
|info=[https://www.ncbi.nlm.nih.gov/pubmed/33401621 PMID: 33401621 Open Access]
|info=[https://www.ncbi.nlm.nih.gov/pubmed/33401621 PMID: 33401621 Open Access] »[[File:O2k-brief.png|36px|link=https://wiki.oroboros.at/images/6/61/Avram_2021_Int_J_Mol_Sci_O2k-brief.pdf|O2k-brief]]
|authors=Avram VF, Chamkha I, Åsander-Frostner E, Ehinger JK, Timar RZ, Hansson MJ, Muntean DM, Elmér E
|authors=Avram Vlad F, Chamkha Imen, Aasander-Frostner Eleonor, Ehinger Johannes K, Timar Romulus Z, Hansson Magnus J, Muntean Danina M, Elmer Eskil
|year=2021
|year=2021
|journal=Int J Mol Sci
|journal=Int J Mol Sci
|abstract=Statins are the cornerstone of lipid-lowering therapy. Although generally well tolerated, statin-associated muscle symptoms (SAMS) represent the main reason for treatment discontinuation. Mitochondrial dysfunction of complex I has been implicated in the pathophysiology of SAMS. The present study proposed to assess the concentration-dependent ex vivo effects of three statins on mitochondrial respiration in viable human platelets and to investigate whether a cell-permeable prodrug of succinate (complex II substrate) can compensate for statin-induced mitochondrial dysfunction. Mitochondrial respiration was assessed by high-resolution respirometry in human platelets, acutely exposed to statins in the presence/absence of the prodrug NV118. Statins concentration-dependently inhibited mitochondrial respiration in both intact and permeabilized cells. Further, statins caused an increase in non-ATP generating oxygen consumption (uncoupling), severely limiting the OXPHOS coupling efficiency, a measure of the ATP generating capacity. Cerivastatin (commercially withdrawn due to muscle toxicity) displayed a similar inhibitory capacity compared with the widely prescribed and tolerable atorvastatin, but did not elicit direct complex I inhibition. NV118 increased succinate-supported mitochondrial oxygen consumption in atorvastatin/cerivastatin-exposed platelets leading to normalization of coupled (ATP generating) respiration. The results acquired in isolated human platelets were validated in a limited set of experiments using atorvastatin in HepG2 cells, reinforcing the generalizability of the findings.
|abstract=Statins are the cornerstone of lipid-lowering therapy. Although generally well tolerated, statin-associated muscle symptoms (SAMS) represent the main reason for treatment discontinuation. Mitochondrial dysfunction of complex I has been implicated in the pathophysiology of SAMS. The present study proposed to assess the concentration-dependent ex vivo effects of three statins on mitochondrial respiration in viable human platelets and to investigate whether a cell-permeable prodrug of succinate (complex II substrate) can compensate for statin-induced mitochondrial dysfunction. Mitochondrial respiration was assessed by high-resolution respirometry in human platelets, acutely exposed to statins in the presence/absence of the prodrug NV118. Statins concentration-dependently inhibited mitochondrial respiration in both intact and permeabilized cells. Further, statins caused an increase in non-ATP generating oxygen consumption (uncoupling), severely limiting the OXPHOS coupling efficiency, a measure of the ATP generating capacity. Cerivastatin (commercially withdrawn due to muscle toxicity) displayed a similar inhibitory capacity compared with the widely prescribed and tolerable atorvastatin, but did not elicit direct complex I inhibition. NV118 increased succinate-supported mitochondrial oxygen consumption in atorvastatin/cerivastatin-exposed platelets leading to normalization of coupled (ATP generating) respiration. The results acquired in isolated human platelets were validated in a limited set of experiments using atorvastatin in HepG2 cells, reinforcing the generalizability of the findings.
|keywords=HepG2 cells, NV118, Cell-permeable succinate, Mitochondria, Platelets, Statins
|keywords=HepG2 cells, NV118, Cell-permeable succinate, Mitochondria, MitoKit-CII, Platelets, Statins
|editor=[[Plangger M]]
|editor=[[Plangger M]]
|mipnetlab=RO Timisoara Muntean DM, SE Lund Elmer E
}}
}}
{{Labeling
{{Labeling
|area=Respiration
|area=Respiration, Pharmacology;toxicology
|organism=Human
|tissues=Platelet
|preparations=Intact cells
|couplingstates=LEAK, ROUTINE, ET
|pathways=ROX
|instruments=Oxygraph-2k
|instruments=Oxygraph-2k
|additional=2021-01
|additional=2021-01, MitoKit-CII, RO, SE, O2k-brief
}}
}}

Revision as of 15:12, 27 April 2021

Publications in the MiPMap
Avram VF, Chamkha I, Åsander-Frostner E, Ehinger JK, Timar RZ, Hansson MJ, Muntean DM, Elmér E (2021) Cell-permeable succinate rescues mitochondrial respiration in cellular models of statin toxicity. Int J Mol Sci 22:424.

» PMID: 33401621 Open Access »O2k-brief

Avram Vlad F, Chamkha Imen, Aasander-Frostner Eleonor, Ehinger Johannes K, Timar Romulus Z, Hansson Magnus J, Muntean Danina M, Elmer Eskil (2021) Int J Mol Sci

Abstract: Statins are the cornerstone of lipid-lowering therapy. Although generally well tolerated, statin-associated muscle symptoms (SAMS) represent the main reason for treatment discontinuation. Mitochondrial dysfunction of complex I has been implicated in the pathophysiology of SAMS. The present study proposed to assess the concentration-dependent ex vivo effects of three statins on mitochondrial respiration in viable human platelets and to investigate whether a cell-permeable prodrug of succinate (complex II substrate) can compensate for statin-induced mitochondrial dysfunction. Mitochondrial respiration was assessed by high-resolution respirometry in human platelets, acutely exposed to statins in the presence/absence of the prodrug NV118. Statins concentration-dependently inhibited mitochondrial respiration in both intact and permeabilized cells. Further, statins caused an increase in non-ATP generating oxygen consumption (uncoupling), severely limiting the OXPHOS coupling efficiency, a measure of the ATP generating capacity. Cerivastatin (commercially withdrawn due to muscle toxicity) displayed a similar inhibitory capacity compared with the widely prescribed and tolerable atorvastatin, but did not elicit direct complex I inhibition. NV118 increased succinate-supported mitochondrial oxygen consumption in atorvastatin/cerivastatin-exposed platelets leading to normalization of coupled (ATP generating) respiration. The results acquired in isolated human platelets were validated in a limited set of experiments using atorvastatin in HepG2 cells, reinforcing the generalizability of the findings. Keywords: HepG2 cells, NV118, Cell-permeable succinate, Mitochondria, MitoKit-CII, Platelets, Statins Bioblast editor: Plangger M O2k-Network Lab: RO Timisoara Muntean DM, SE Lund Elmer E


Labels: MiParea: Respiration, Pharmacology;toxicology 


Organism: Human  Tissue;cell: Platelet  Preparation: Intact cells 


Coupling state: LEAK, ROUTINE, ET  Pathway: ROX  HRR: Oxygraph-2k 

2021-01, MitoKit-CII, RO, SE, O2k-brief